This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...
CNW/ - Highlights A$14.1M Entitlement Offer Fully Subscribed Completion of Entitlement Offer to all eligible shareholders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback